ES2116522T3 - Compuestos citotoxicos. - Google Patents

Compuestos citotoxicos.

Info

Publication number
ES2116522T3
ES2116522T3 ES94300778T ES94300778T ES2116522T3 ES 2116522 T3 ES2116522 T3 ES 2116522T3 ES 94300778 T ES94300778 T ES 94300778T ES 94300778 T ES94300778 T ES 94300778T ES 2116522 T3 ES2116522 T3 ES 2116522T3
Authority
ES
Spain
Prior art keywords
compounds
cytotoxic compounds
mpta
antitumoral
presented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94300778T
Other languages
English (en)
Inventor
Jun-Ichi Tanaka
Tatsuo Higa
Khanit Suwanoborirux
Charles William Jefford
Gerald Bernardinelli
Dolores Garcia Gravalos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Application granted granted Critical
Publication of ES2116522T3 publication Critical patent/ES2116522T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/11Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/021,2-Dioxanes; Hydrogenated 1,2-dioxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

SE PRESENTAN COMPUESTOS AISLADOS A PARTIR DE UNA ESPONJA MARINA Y DERIVADOS DE LOS MISMOS QUE TIENEN LAS FORMULAS (I) Y (II) EN DONDE R1 ES H O ALQUILO INFERIOR; R2 ES OH O CH3; R3 ES OH O CH3, Y R4 ES H O MPTA. LOS COMPUESTOS TIENEN ACTIVIDAD ANTITUMORAL Y ANTIVIRAL. LA INVENCION TAMBIEN SE REFIERE A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN LOS COMPUESTOS Y A METODOS DE TRATAMIENTO QUE LOS EMPLEAN.
ES94300778T 1993-02-03 1994-02-02 Compuestos citotoxicos. Expired - Lifetime ES2116522T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302044A GB9302044D0 (en) 1993-02-03 1993-02-03 Cytotoxic compounds i

Publications (1)

Publication Number Publication Date
ES2116522T3 true ES2116522T3 (es) 1998-07-16

Family

ID=10729726

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94300778T Expired - Lifetime ES2116522T3 (es) 1993-02-03 1994-02-02 Compuestos citotoxicos.

Country Status (11)

Country Link
US (1) US5449684A (es)
EP (1) EP0610076B1 (es)
JP (1) JPH0769884A (es)
AT (1) ATE165094T1 (es)
AU (1) AU674366B2 (es)
CA (1) CA2114777A1 (es)
DE (1) DE69409553T2 (es)
DK (1) DK0610076T3 (es)
ES (1) ES2116522T3 (es)
GB (1) GB9302044D0 (es)
ZA (1) ZA94746B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541515B2 (en) * 2000-08-09 2003-04-01 Merck & Co., Inc. HIV integrase inhibitors
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731377A (en) * 1986-01-31 1988-03-15 Harbor Branch Oceanographic Institute, Inc. Antitumor cyclic peroxides
US5183924A (en) * 1989-01-24 1993-02-02 Lipha, Lyonnaise Industrielle Pharmaceutique Derivatives of benzocycloalkenyldihydroxyalkanoic acids, processes of preparation and medications containing them

Also Published As

Publication number Publication date
EP0610076B1 (en) 1998-04-15
AU5491094A (en) 1994-08-11
DE69409553D1 (de) 1998-05-20
AU674366B2 (en) 1996-12-19
JPH0769884A (ja) 1995-03-14
EP0610076A1 (en) 1994-08-10
GB9302044D0 (en) 1993-03-24
US5449684A (en) 1995-09-12
CA2114777A1 (en) 1994-08-04
ZA94746B (en) 1994-09-29
DK0610076T3 (da) 1999-01-25
ATE165094T1 (de) 1998-05-15
DE69409553T2 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
AR015103A1 (es) Compuestos derivados de 6,6-heterobiciclicos sustituidos y composiciones que los contienen e intermediarios
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
ES2124479T3 (es) Composiciones biocidas.
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
BG103485A (en) Ketobanzamides as calpain inhibitors
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
FR2571966B1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
DK1224940T3 (da) Flydende formuleringer af interferon-beta
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2104090T3 (es) Nuevas 3',5'-di-t-butil-4'-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
KR960702830A (ko) 방사선 보호제로서의 N-알킬티오 폴리아민 유도체(N-Alkylthio polyaine derivatives as radioprotective agents)
ES8403472A1 (es) Procedimiento para la obtencion de un medio para combatir las pestes a base de como minimo de aminocetal.
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
DK0536197T3 (da) Ren, krystallinsk form af rifapentine
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ATE350109T1 (de) Kosmetische und dermatologische lichtshutzformulierungen mit einem gehalt an unsymmetrisch substituierten triazinderivaten und alkylnaphthalaten
DE69108740D1 (de) Herstellung von peroxidzusammensetzungen.
ES2116522T3 (es) Compuestos citotoxicos.
ES2076838T3 (es) Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen.
ZA872664B (en) Six-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 610076

Country of ref document: ES